1 Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine , New Haven, Connecticut.
Tissue Eng Part A. 2014 Jan;20(1-2):346-55. doi: 10.1089/ten.TEA.2012.0613. Epub 2013 Nov 14.
We previously developed and validated a murine model for investigating neotissue formation in tissue-engineered vascular grafts (TEVGs). Herein, we present the first longitudinal assessment of both the microstructural composition and the mechanical properties of a TEVG through the process of neovessel formation (total scaffold degradation). We show that when (poly)glycolic acid-based biodegradable scaffolds were used as inferior vena cava interposition grafts in mice, the evolving neovessel developed biaxial properties that approached those of the native vein within 24 weeks of implantation. Further, we found that these changes in biaxial properties related temporally to extracellular matrix production and remodeling, including deposition of collagen (types I and III), elastic fibers (elastin and fibrillin-1), and glycosaminoglycans in addition to changes in matrix metalloproteinase (MMP)-2 and -9 activity. Improving our understanding of the mechanobiological principles underlying vascular neotissue formation in TEVGs holds great promise for improving the design of TEVGs and enabling us to continue the translation of this technology from the bench to the clinic.
我们之前开发并验证了一种用于研究组织工程血管移植物(TEVG)中新组织形成的鼠模型。在此,我们通过新血管形成(总支架降解)的过程,首次对 TEVG 的微观结构组成和力学性能进行了纵向评估。我们发现,当(聚)乙交酯基可生物降解支架作为下腔静脉间置移植物用于小鼠时,在植入后 24 周内,新形成的血管具有接近天然静脉的双轴特性。此外,我们发现,双轴特性的这些变化与细胞外基质的产生和重塑有关,包括胶原蛋白(I 型和 III 型)、弹性纤维(弹性蛋白和原纤维蛋白-1)和糖胺聚糖的沉积,以及基质金属蛋白酶(MMP)-2 和 -9 活性的变化。深入了解 TEVG 中新血管形成的力学生物学原理,有望改进 TEVG 的设计,并使我们能够将这项技术从实验室推向临床。